Skip to main content
. 2020 Aug 4;2020:1501893. doi: 10.1155/2020/1501893

Figure 2.

Figure 2

Self-assessment evaluation of patients based on questionnaires. (a) Degree of improvement on symptoms of scalp oil secretion, pruritus, and dandruff. (b) Degree of improvement on reduction in hair loss. BTA: botulinum toxin type A; BTA+FNS: botulinum toxin type A+finasteride.